VitaDX will be present at EAU24

VitaDX will be present at the 36th European Association of Urology congress from April 5 to 8, at Paris Expo Porte de Versailles. 
 

Visit us at booth C86 to learn more about Visiocyt® Bladder - the first CE IVDR-marked AI-based non-invasive test for the management and follow-up of patients with bladder cancer.

We look forward to discussing this innovation solution in urology with you.